6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Ichthyosis: new trials by email Literature Review of Ichthyosis trials Research Report on Ichthyosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis TMB-001, Matching Vehicle - Ichthyosis | Phase 3 | Completed | LEO Pharma | 153 | 2022-06-21 | 2026-05-22 |
| RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS) ADX-102 1% Topical Dermal Cream (reproxalap), Vehicle of ADX-102 Topical Dermal Cream - Sjogren-Larsson Syndrome | Phase 3 | Completed | Aldeyra Therapeutics, Inc. | 11 | 2018-07-18 | 2023-02-09 |
| Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side - Lamellar Ichthyosis | Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 6 | 2010-10-01 | 2026-06-17 |
| Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) Rezular 15mg, Placebo, Rezular - Irritable Bowel Syndrome With Diarrhea | Phase 3 | Completed | AGI Therapeutics, Inc. | 711 | 2007-09-01 | 2009-06-11 |
| Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis Liarozole - Ichthyosis, Lamellar | Phase 2 / Phase 3 | Completed | Stiefel, a GSK Company | 98 | 2006-01-01 | 2011-09-26 |
| Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis monolaurin cream - Ichthyosis | Phase 3 | Completed | Cellegy Pharmaceuticals | 90 | 1996-09-01 | 2015-03-25 |
Ichthyosis, Lamellar (2) · Ichthyosis Bullosa of Siemens (1) · Rare Diseases (1) · Sjogren-Larsson Syndrome (1) · Skin Diseases (1)
Congenital Abnormalities (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Infant, Newborn, Diseases (6) · Keratosis (6) · Skin Abnormalities (6) · Skin and Connective Tissue Diseases (6) · Skin Diseases (5) · Genetic Diseases, Inborn (4) · Skin Diseases, Genetic (4) · Ichthyosiform Erythroderma, Congenital (2) · Disease Attributes (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Lipidoses (1)
Skin Cream (1) · liarozole (1) · reproxalap (1)
AGI Therapeutics, Inc. (1) · Aldeyra Therapeutics, Inc. (1) · Cellegy Pharmaceuticals (1) · Centre Hospitalier Universitaire de Nice (1) · LEO Pharma (1) · Stiefel, a GSK Company (1)
France (3) · United States (3) · Canada (2) · Germany (2) · Italy (2) · Belgium (1) · Dominican Republic (1) · Netherlands (1) · Norway (1) · Sweden (1)
Carl R. Thornfeldt (1) · Chiaverini Christine, Dr (1) · Koen van Rossem, MD, PhD (1)